Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Hull

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
HIV/AIDS (Auckland, N.Z.)|March 24, 2017
Can the HIV-1 splicing machinery be targeted for drug discovery?Zodwa Dlamini, Rodney Hull
Parasites & Vectors|January 30, 2014
The role played by alternative splicing in antigenic variability in human endo-parasitesRodney Hull, Zodwa Dlamini
Anti-Cancer Drugs|August 19, 2010
Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatmentRodney Hull, Monde McMillan Ntwasa
Biomedicines|October 27, 2022
Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-MakingSikhumbuzo Mbatha, Rodney Hull, Zodwa Dlamini
American Journal of Cancer Research|April 1, 2021
Long non-coding RNAs (LncRNAs), viral oncogenomics, and aberrant splicing events: therapeutics implicationsRodney Hull, Zukile Mbita, Zodwa Dlamini
Experimental and Molecular Pathology|August 12, 2017
African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugsMzwandile Mbele, Rodney Hull, Zodwa Dlamini
Journal of Molecular Endocrinology|July 19, 2017
Abnormalities in alternative splicing in diabetes: therapeutic targetsZodwa Dlamini, Fortunate Mokoena, Rodney Hull
American Journal of Cancer Research|October 12, 2020
Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkersZodwa Dlamini, Bonginkosi Shoba, Rodney Hull
Genes|January 21, 2022
LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic OpportunitiesPeace Mabeta, Rodney Hull, Zodwa Dlamini
Viruses|September 9, 2014
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targetsZukile Mbita, Rodney Hull, Zodwa Dlamini
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
HIV/AIDS (Auckland, N.Z.)|March 24, 2017
Can the HIV-1 splicing machinery be targeted for drug discovery?Zodwa Dlamini, Rodney Hull
Parasites & Vectors|January 30, 2014
The role played by alternative splicing in antigenic variability in human endo-parasitesRodney Hull, Zodwa Dlamini
Anti-Cancer Drugs|August 19, 2010
Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatmentRodney Hull, Monde McMillan Ntwasa
Biomedicines|October 27, 2022
Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-MakingSikhumbuzo Mbatha, Rodney Hull, Zodwa Dlamini
American Journal of Cancer Research|April 1, 2021
Long non-coding RNAs (LncRNAs), viral oncogenomics, and aberrant splicing events: therapeutics implicationsRodney Hull, Zukile Mbita, Zodwa Dlamini
Experimental and Molecular Pathology|August 12, 2017
African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugsMzwandile Mbele, Rodney Hull, Zodwa Dlamini
Journal of Molecular Endocrinology|July 19, 2017
Abnormalities in alternative splicing in diabetes: therapeutic targetsZodwa Dlamini, Fortunate Mokoena, Rodney Hull
American Journal of Cancer Research|October 12, 2020
Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkersZodwa Dlamini, Bonginkosi Shoba, Rodney Hull
Genes|January 21, 2022
LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic OpportunitiesPeace Mabeta, Rodney Hull, Zodwa Dlamini
Viruses|September 9, 2014
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targetsZukile Mbita, Rodney Hull, Zodwa Dlamini
Pageof 7